News
Earnings Preview: UnitedHealth reports 2Q earnings
July 16, 2010 10:45 am | by The Associated Press | CommentsManaged care company UnitedHealth Group Inc. reports second-quarter results July 20 before the market opens.WHAT TO WATCH FOR: The Minnetonka, Minn., insurer started 2010 strong. It reported a 21 percent year-over-year profit jump in the first quarter and said it had trimmed the percentage of...
Adjusting Market Research Structures and Activities to Maximize Payer Access & Insights
July 16, 2010 9:35 am | by Bio-Medicine.Org | CommentsCHAPEL HILL, N.C. , July 16 /- As the managed markets sector has increased in importance, leading organizations have refocused their market research efforts on delivering actionable insights into the payer world. A market research function that's focused on managed markets should provide...
Health Management names Levine senior VP
July 16, 2010 7:45 am | by The Associated Press | CommentsHospital operator Health Management Associates Inc. said Friday it named Alan Levine as its new senior vice president of health development operations and government relations.The appointment is effective Aug. 9.Levine most recently served as Secretary of the Louisiana Department of Health and...
Warner Chilcott Announces 3-Month Extension of PDUFA Date on Next Generation Actonel Product
July 16, 2010 7:36 am | by Bio-Medicine.Org | CommentsARDEE, Ireland , July 16 /- Warner Chilcott plc (Nasdaq: WCRX ) announced today that it has received a communication from the U.S. Food & Drug Administration (FDA) related to its next generation Actonel® product (risedronate sodium) delayed-release tablets extending the...
Siemens Primed to Help Customers Achieve Newly-Defined Criteria for 'Meaningful Use' of an Electronic Health Record
July 16, 2010 7:36 am | by Bio-Medicine.Org | CommentsMALVERN, Pa. , July 16 /- Today, Siemens Healthcare announced that the newly-released Final Rule on 'Meaningful Use' of Electronic Health Records (EHRs) provides an important boost to its ongoing campaign to help healthcare providers realize quality and efficiency gains through the use of...
Roper Industries Announces Senior Subordinated Convertible Notes Due 2034 to Accrue Contingent Cash Interest and Conversion Rate Adjustment
July 16, 2010 7:36 am | by Bio-Medicine.Org | CommentsSARASOTA, Fla. , July 16 /- Roper Industries, Inc. (NYSE: ROP ) announced today that its Senior Subordinated Convertible Notes due 2034 (CUSIP No. 776696AA4) (the "Notes") will accrue contingent interest for the period of July 16, 2010 to January 15, 2011 at an annual rate of 0.25% of the...
GTC regains U.S. rights to ATryn blood clot therapeutic
July 16, 2010 7:35 am | by Mass High Tech: The Journal of New England Technology | CommentsGTC Biotherapeutics Inc., a developer of drug therapies derived from animal proteins, has regained U.S. commercialization rights to ATryn, a drug intended to prevent blood clots, from Lundbeck Inc., a wholly owned subsidiary of H. Lundbeck A/S in Denmark.
Amedisys defends company in shareholder letter
July 16, 2010 5:45 am | by The Associated Press | CommentsAmedisys Inc. has issued a letter to its shareholders defending its home health care practices that have fallen under federal investigation.In the 21-page letter, released after financial markets closed Thursday, Amedisys challenged questions raised by The Wall Street Journal, which examined...
Cardinal Health Completes Acquisition of Healthcare Solutions Holding
July 15, 2010 2:38 pm | by Bio-Medicine.Org | CommentsDUBLIN, Ohio , July 15 /- Cardinal Health today completed the previously announced acquisition of Healthcare Solutions Holding, LLC, expanding the company's presence in specialty pharmaceutical services. Healthcare Solutions Holding is the parent company of a number of subsidiaries...
Noscira Presents Results of Phase IIa Clinical Trial with Nypta(R) (Tideglusib) on Alzheimer's Disease at International Conference on Alzheimer's Disease (ICAD)
July 15, 2010 2:38 pm | by Bio-Medicine.Org | Comments- Treatment with Nypta(R) (Tideglusib) (NP-12) was tolerated and produced positive effects on Alzheimer's patients in four of the five efficacy variables examined in the trial. - In view of the promising results of this trial, Noscira is preparing the next Phase IIb trial on Alzheimer's...
Dynatronics Launches E-Commerce Website
July 15, 2010 2:38 pm | by Bio-Medicine.Org | CommentsSALT LAKE CITY , July 15 /- Dynatronics Corporation (Nasdaq: DYNT ) today announced the launch of its e-commerce website at dynatronics.com . The new website offers thousands of products for clinics and medical practitioners, particularly targeting the physical medicine market. "The...
New method of tissue banking makes gene analysis more practical for lung cancer
July 15, 2010 2:35 pm | by EurekAlert | Comments(International Association for the Study of Lung Cancer) Analyzing the genes expressed by cancer cells allows for a better understanding of that patient's specific disease and in turn, a more personalized approach to treatment. But obtaining the RNA from a tumor in the lungs in...
AngioDynamics fiscal 4Q net income up 29 percent
July 15, 2010 1:45 pm | by The Associated Press | CommentsMedical device maker AngioDynamics Inc. said Thursday its fiscal fourth-quarter net income rose 29 percent, helped by higher sales of peripheral vascular, and oncology and surgery products.For the three months ended May 31, AngioDynamics' net income increased to $3.7 million, or 15 cents per...
AngioDynamics' profit guidance lower than expected
July 15, 2010 1:45 pm | by The Associated Press | CommentsMedical device maker AngioDynamics Inc. issued earnings guidance Thursday that is lower than Wall Street is expecting, but revenue guidance range was higher than analysts' average forecast.AngioDynamics said it expects net income of 53 cents to 56 cents per share for the fiscal year, which ends...
Class I Medical Device Recall: Symbiq One-Channel Infuser and Symbiq Two-Channel Infuser
July 15, 2010 12:32 pm | by U.S. Food & Drug Administration | CommentsThere is potential for the device to fail to detect air in line at the end of an infusion.
